Walter E Aulitzky
Overview
Explore the profile of Walter E Aulitzky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
869
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Schmid J, Dong M, Haubeiss S, Friedel G, Bode S, Grabner A, et al.
Cancer Res
. 2012 Sep;
72(22):5824-32.
PMID: 22962266
Current understanding of the p53 response is based mainly upon in vitro studies of homogeneous cell populations. However, there is little information on whether the same principles operate within heterogeneous...
22.
Dengler M, Staiger A, Gutekunst M, Hofmann U, Doszczak M, Scheurich P, et al.
PLoS One
. 2011 Sep;
6(9):e25139.
PMID: 21949869
In response to deregulated oncogene activation, mammalian cells activate disposal programs such as programmed cell death. To investigate the mechanisms behind this oncogenic stress response we used Bcr-Abl over-expressing cells...
23.
Gutekunst M, Oren M, Weilbacher A, Dengler M, Markwardt C, Thomale J, et al.
PLoS One
. 2011 May;
6(4):e19198.
PMID: 21532991
Consistent with the excellent clinical results in testicular germ cell tumors (TGCT), most cell lines derived from this cancer show an exquisite sensitivity to Cisplatin. It is well accepted that...
24.
Haubeiss S, Schmid J, Murdter T, Sonnenberg M, Friedel G, van der Kuip H, et al.
Mol Cancer
. 2010 Jun;
9:168.
PMID: 20579391
Cancer associated fibroblasts (CAFs) play a critical role for growth, invasion, and metastasis of cancer. Therefore, targeting CAFs with small molecule inhibitors may be an attractive anti-tumor strategy. The current...
25.
Skorta I, Oren M, Markwardt C, Gutekunst M, Aulitzky W, van der Kuip H
Cancer Res
. 2009 Nov;
69(24):9337-45.
PMID: 19934315
Imatinib is highly effective in inducing remission in chronic myelogenous leukemia (CML). However, complete eradication of the malignant clone by imatinib is rare. We investigated the efficacy of combining imatinib...
26.
Sonnenberg M, van der Kuip H, Haubeis S, Fritz P, Schroth W, Friedel G, et al.
BMC Cancer
. 2008 Dec;
8:364.
PMID: 19077243
Background: Carcinoma-associated fibroblasts (CAFs) can promote carcinogenesis and tumor progression. Only limited data on the response of CAFs to chemotherapy and their potential impact on therapy outcome are available. This...
27.
Henkes M, van der Kuip H, Aulitzky W
Ther Clin Risk Manag
. 2008 Aug;
4(1):163-87.
PMID: 18728706
Treatment options for chronic myeloid leukemia (CML) have changed dramatically during the last decades. Interferon-alpha treatment and stem cell transplantation (SCT) clearly improved survival over conventional chemotherapy and offered the...
28.
Olofsson M, Ueno T, Pan Y, Xu R, Cai F, van der Kuip H, et al.
Clin Cancer Res
. 2007 Jun;
13(11):3198-206.
PMID: 17545523
Purpose: With a widening arsenal of cancer therapies available, it is important to develop therapy-specific predictive markers and methods to rapidly assess treatment efficacy. We here evaluated the use of...
29.
Schuler U, Bammer S, Aulitzky W, Binder C, Bohme A, Egerer G, et al.
Onkologie
. 2007 Mar;
30(4):185-91.
PMID: 17396041
Background: Safety, tolerability and efficacy of itraconazole and amphotericin B (AMB) were compared for empirical antifungal treatment of febrile neutropenic cancer patients. Patients And Methods: In an open, randomised study,...
30.
van der Kuip H, Murdter T, Sonnenberg M, McClellan M, Gutzeit S, Gerteis A, et al.
BMC Cancer
. 2006 Apr;
6:86.
PMID: 16603054
Background: Sensitivity of breast tumors to anticancer drugs depends upon dynamic interactions between epithelial tumor cells and their microenvironment including stromal cells and extracellular matrix. To study drug-sensitivity within different...